Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123515314 | 12351531 | 4 | F | 20150228 | 20160805 | 20160510 | 20160812 | EXP | PHHY2016CO031700 | NOVARTIS | 59.85 | YR | F | Y | 48.00000 | KG | 20160812 | CN | CO | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123515314 | 12351531 | 1 | PS | VOTRIENT | PAZOPANIB HYDROCHLORIDE | 1 | Oral | 200 MG, BID | N | 22465 | 200 | MG | TABLET | BID | |||||
| 123515314 | 12351531 | 2 | SS | VOTRIENT | PAZOPANIB HYDROCHLORIDE | 1 | Oral | 1 TABLET AND A HALF AT NIGHT (300 MG) | N | 22465 | TABLET | ||||||||
| 123515314 | 12351531 | 3 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD (EVERY EVENING) | 0 | 10 | MG | TABLET | QD | ||||||
| 123515314 | 12351531 | 4 | C | LEPRIT | 2 | Unknown | UNK, QD | U | 0 | QD | |||||||||
| 123515314 | 12351531 | 5 | C | LASIX | FUROSEMIDE | 1 | Unknown | 400 MG, UNK | U | 0 | 400 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123515314 | 12351531 | 1 | Renal cell carcinoma |
| 123515314 | 12351531 | 3 | Renal cell carcinoma |
| 123515314 | 12351531 | 4 | Flatulence |
| 123515314 | 12351531 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123515314 | 12351531 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123515314 | 12351531 | Abdominal distension | |
| 123515314 | 12351531 | Abdominal pain | |
| 123515314 | 12351531 | Aggression | |
| 123515314 | 12351531 | Alopecia | |
| 123515314 | 12351531 | Blood iron decreased | |
| 123515314 | 12351531 | Diarrhoea | |
| 123515314 | 12351531 | Dizziness | |
| 123515314 | 12351531 | Haemoglobin decreased | |
| 123515314 | 12351531 | Malaise | |
| 123515314 | 12351531 | Off label use | |
| 123515314 | 12351531 | Onychoclasis | |
| 123515314 | 12351531 | Peripheral swelling | |
| 123515314 | 12351531 | Poisoning | |
| 123515314 | 12351531 | Pulmonary mass | |
| 123515314 | 12351531 | Tooth injury | |
| 123515314 | 12351531 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123515314 | 12351531 | 1 | 20150228 | 0 | ||
| 123515314 | 12351531 | 2 | 20160503 | 0 | ||
| 123515314 | 12351531 | 3 | 20160521 | 20160624 | 0 |